Drug Shortage Report for APO-PERINDOPRIL-INDAPAMIDE
Report ID | 186580 |
Drug Identification Number | 02453061 |
Brand name | APO-PERINDOPRIL-INDAPAMIDE |
Common or Proper name | PERIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | PERINDOPRIL ERBUMINE INDAPAMIDE |
Strength(s) | 8MG 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-03-07 |
Estimated end date | 2023-09-22 |
Actual end date | 2022-09-14 |
Shortage status | Avoided shortage |
Updated date | 2023-09-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v30 | 2023-09-15 | French | Compare |
v29 | 2023-09-15 | English | Compare |
v28 | 2023-09-07 | French | Compare |
v27 | 2023-09-07 | English | Compare |
v26 | 2023-09-01 | French | Compare |
v25 | 2023-09-01 | English | Compare |
v24 | 2023-08-04 | French | Compare |
v23 | 2023-08-04 | English | Compare |
v22 | 2023-07-21 | French | Compare |
v21 | 2023-07-21 | English | Compare |
v20 | 2023-07-13 | French | Compare |
v19 | 2023-07-13 | English | Compare |
v18 | 2023-07-07 | French | Compare |
v17 | 2023-07-07 | English | Compare |
v16 | 2023-06-29 | French | Compare |
v15 | 2023-06-29 | English | Compare |
v14 | 2023-06-23 | French | Compare |
v13 | 2023-06-23 | English | Compare |
v12 | 2023-06-02 | French | Compare |
v11 | 2023-06-02 | English | Compare |